Accent Microcell Ltd
₹ 240
-2.59%
21 Nov
- close price
About
Incorporated in 2001, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]
Key Points
- Market Cap ₹ 506 Cr.
- Current Price ₹ 240
- High / Low ₹ 364 / 224
- Stock P/E 15.5
- Book Value ₹ 84.7
- Dividend Yield 0.42 %
- ROCE 31.0 %
- ROE 28.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.8%
Cons
- Debtor days have increased from 57.9 to 80.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|
| 131 | 133 | 166 | 197 | 246 | 265 | |
| 122 | 122 | 153 | 178 | 206 | 226 | |
| Operating Profit | 9 | 11 | 13 | 19 | 39 | 39 |
| OPM % | 7% | 8% | 8% | 10% | 16% | 15% |
| 4 | 2 | 2 | 2 | 3 | 5 | |
| Interest | 3 | 3 | 3 | 3 | 1 | 0 |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 6 | 6 | 8 | 15 | 37 | 39 |
| Tax % | 31% | 20% | 22% | 17% | 17% | |
| 4 | 5 | 6 | 12 | 30 | 33 | |
| EPS in Rs | 9.72 | 11.16 | 4.56 | 9.45 | 14.34 | 15.47 |
| Dividend Payout % | 0% | 0% | 18% | 8% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 23% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 86% |
| TTM: | 153% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 28% |
| Last Year: | 29% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 4 | 13 | 13 | 21 | 21 |
| Reserves | 21 | 19 | 37 | 143 | 157 |
| 30 | 24 | 23 | 13 | 2 | |
| 22 | 38 | 37 | 28 | 26 | |
| Total Liabilities | 77 | 95 | 111 | 205 | 206 |
| 29 | 30 | 31 | 29 | 46 | |
| CWIP | 0 | 0 | 0 | 2 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 48 | 64 | 79 | 174 | 155 | |
| Total Assets | 77 | 95 | 111 | 205 | 206 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 5 | 5 | 15 | 8 | 11 | |
| -2 | -6 | -4 | -4 | -82 | |
| -2 | -2 | -10 | -4 | 72 | |
| Net Cash Flow | 1 | -3 | 1 | -1 | 1 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 60 | 38 | 56 | 80 | |
| Inventory Days | 78 | 128 | 128 | 82 | |
| Days Payable | 80 | 97 | 106 | 48 | |
| Cash Conversion Cycle | 58 | 68 | 79 | 114 | |
| Working Capital Days | 59 | 54 | 73 | 96 | |
| ROCE % | 27% | 31% |
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
20 November 2024 - Accent Microcell Limited has informed about Updates about Investors meet
-
Outcome of Board Meeting
20 November 2024 - Accent Microcell Limited has informed regarding Board meeting held on November 20, 2024 to consider and approve the Restated Financial Statements in connection with the …
-
Board Meeting Intimation
15 November 2024 - ACCENT MICROCELL LIMITED has informed about Board Meeting to be held on 20-Nov-2024 to consider Other business.
-
Analysts/Institutional Investor Meet/Con. Call Updates
15 November 2024 - Accent Microcell Limited has informed about Schedule of meet
-
Rights Issue
29 October 2024 - Board at its meeting held on October 29, 2024, has decided to issue equity shares on rights basis.
Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.